The VITAL study: A randomized, double-blind, placebo-controlled, global, phase III study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction Meeting Abstract
| Authors: | Liedtke, M.; Merlini, G.; Landau, H. J.; Comenzo, R.; Seldin, D. C.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G.; Koller, M.; Gertz, M. A. |
| Abstract Title: | The VITAL study: A randomized, double-blind, placebo-controlled, global, phase III study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036904876 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.8614 |
| Notes: | Meeting Abstract: TPS8614 -- Source: Wos |
